When patients worry about being judged
Heart Sisters
SEPTEMBER 29, 2024
There’s a lot of judgey judging of chronically ill patients going on out there.
Sun.Sep 29, 2024
123 
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction
JAMA Cardiology
SEPTEMBER 29, 2024
The EMBARK-HFpEF multicenter, open-label trial examines the effects of cardiac myosin inhibition with mavacamten in patients with heart failure with preserved ejection fraction with a left ventricular ejection fraction of 60% or greater.
Christie Ballantyne, MD: 'Exciting' Time for FCS Pipeline
HCPLive
SEPTEMBER 29, 2024
A comparison of the PALISADE and BALANCE trials, with commentary from a leading cardiologist, as the community nears a potential approval in FCS.
New FINEARTS-HF Analyses Further Explore Impacts of Finerenone in Patients With HFmrEF and HFpEF
American College of Cardiology
SEPTEMBER 29, 2024
Steroidal mineralocorticoid receptor antagonists like finerenone lower mortality in patients with heart failure and reduced ejection fraction (HFrEF), but more data are needed for patients with heart failure and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF). Findings from the recent FINEARTS-HF trial presented during the ESC Congress 2024 and more recently HFSA 2024 are helping to address this need.
Exposure of cumulative atherogenic index of plasma and the development of prediabetes in middle-aged and elderly individuals: evidence from the CHARLS cohort study
Cardiovascular Diabetology
SEPTEMBER 29, 2024
The impact of dynamic changes in the degree of atherosclerosis on the development of prediabetes remains unclear. This study aims to investigate the association between cumulative atherogenic index of plasma (.
Does Finerenone's Efficacy Diminish if Initiated Late in Heart Failure?
Med Page Today
SEPTEMBER 29, 2024
(MedPage Today) -- The benefit-risk profile of finerenone (Kerendia) for heart failure and mildly reduced or preserved ejection fraction (HFmrEF, HFpEF) was arguably unchanged with delayed initiation, according to the FINEARTS-HF trial. An analysis.
Clinical Quiz: Long-term Gout Management and Special Considerations from 2020 ACR Gout Guidelines
HCPLive
SEPTEMBER 29, 2024
This clinical quiz, our last in a series of 4, focuses on recommendations for special populations and long-term management from the 2020 ACR gout guidelines.
Sign up to get articles personalized to your interests!
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
More Trending
Retinitis Pigmentosa Diagnosis Intensifies Risk of Depressive Disorder
HCPLive
SEPTEMBER 29, 2024
Individuals diagnosed with retinitis pigmentosa experienced an elevated risk of depressive disorder, compared with the general Korean population.
Coronary Artery Bypass Grafting: Past and Future
Circulation
SEPTEMBER 29, 2024
Circulation, Volume 150, Issue 14 , Page 1067-1069, October 1, 2024.
Impact of Blood Pressure Management on Cardiovascular Events among Patients with Familial Hypercholesterolemia: Hypertension among FH
The American Journal of Cardiology
SEPTEMBER 29, 2024
Publication date: Available online 28 September 2024 Source: The American Journal of Cardiology Author(s): Hayato Tada, Nobuko Kojima, Yasuaki Takeji, Atsushi Nohara, Masa-aki Kawashiri, Masayuki Takamura
50 yo with V fib has ROSC, then these 2 successive ECGs: what is the infarct artery?
Dr. Smith's ECG Blog
SEPTEMBER 29, 2024
A 50 yo was resuscitated from ventricular fibrillation. He had a prehospital ECG recorded after ROSC: What do you think? This certainly looks like an anterior STEMI (proximal LAD occlusion), with STE and hyperacute T-waves (HATW) in V2-V6 and I and aVL. Although one may have all kinds of ischemic findings as a result of cardiac arrest (rather than cause of cardiac arrest), this degree of ST elevation and HATW is all but diagnostic of acute proximal LAD occlusion.
Let's personalize your content